EE02958B1 - Prolongeeritud toimega preparaat, polümeeride segu selle valmistamiseks ja polümeeride segu valmistamismeetod - Google Patents

Prolongeeritud toimega preparaat, polümeeride segu selle valmistamiseks ja polümeeride segu valmistamismeetod

Info

Publication number
EE02958B1
EE02958B1 EE9400413A EE9400413A EE02958B1 EE 02958 B1 EE02958 B1 EE 02958B1 EE 9400413 A EE9400413 A EE 9400413A EE 9400413 A EE9400413 A EE 9400413A EE 02958 B1 EE02958 B1 EE 02958B1
Authority
EE
Estonia
Prior art keywords
preparation
polymer blend
prolonged
release
drug
Prior art date
Application number
EE9400413A
Other languages
English (en)
Estonian (et)
Inventor
Yamada Minoru
Ishiguro Seiko
Ogawa Yasuaki
Original Assignee
Takeda Chemical Industries, Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries, Ltd. filed Critical Takeda Chemical Industries, Ltd.
Publication of EE02958B1 publication Critical patent/EE02958B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/745—Polymers of hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L67/00—Compositions of polyesters obtained by reactions forming a carboxylic ester link in the main chain; Compositions of derivatives of such polymers
    • C08L67/04—Polyesters derived from hydroxycarboxylic acids, e.g. lactones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
EE9400413A 1990-10-16 1994-11-17 Prolongeeritud toimega preparaat, polümeeride segu selle valmistamiseks ja polümeeride segu valmistamismeetod EE02958B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP27803790 1990-10-16
JP21704591 1991-08-28

Publications (1)

Publication Number Publication Date
EE02958B1 true EE02958B1 (et) 1997-02-17

Family

ID=26521778

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9400413A EE02958B1 (et) 1990-10-16 1994-11-17 Prolongeeritud toimega preparaat, polümeeride segu selle valmistamiseks ja polümeeride segu valmistamismeetod

Country Status (24)

Country Link
US (1) US5304377A (es)
EP (1) EP0481732B1 (es)
JP (1) JP3196035B2 (es)
KR (1) KR100199119B1 (es)
CN (2) CN1043189C (es)
AT (1) ATE119035T1 (es)
AU (1) AU644019B2 (es)
CA (1) CA2053468C (es)
DE (1) DE69107773T2 (es)
DK (1) DK0481732T3 (es)
EE (1) EE02958B1 (es)
ES (1) ES2069221T3 (es)
FI (1) FI101454B1 (es)
GE (1) GEP19981287B (es)
IE (1) IE66705B1 (es)
LT (1) LT3277B (es)
LV (1) LV10055B (es)
MX (1) MX9101595A (es)
NO (1) NO302481B1 (es)
NZ (1) NZ240214A (es)
PT (1) PT99236B (es)
RU (1) RU2103005C1 (es)
UA (1) UA27707C2 (es)
ZA (1) ZA918168B (es)

Families Citing this family (92)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6323307B1 (en) 1988-08-08 2001-11-27 Cargill Dow Polymers, Llc Degradation control of environmentally degradable disposable materials
US5142023A (en) * 1992-01-24 1992-08-25 Cargill, Incorporated Continuous process for manufacture of lactide polymers with controlled optical purity
US5258488A (en) * 1992-01-24 1993-11-02 Cargill, Incorporated Continuous process for manufacture of lactide polymers with controlled optical purity
US6005067A (en) * 1992-01-24 1999-12-21 Cargill Incorporated Continuous process for manufacture of lactide polymers with controlled optical purity
US6326458B1 (en) 1992-01-24 2001-12-04 Cargill, Inc. Continuous process for the manufacture of lactide and lactide polymers
US5247058A (en) * 1992-01-24 1993-09-21 Cargill, Incorporated Continuous process for manufacture of lactide polymers with controlled optical purity
US5247059A (en) * 1992-01-24 1993-09-21 Cargill, Incorporated Continuous process for the manufacture of a purified lactide from esters of lactic acid
AU5294893A (en) * 1992-10-02 1994-04-26 Cargill Incorporated A melt-stable lactide polymer fabric and process for manufacture thereof
US6005068A (en) 1992-10-02 1999-12-21 Cargill Incorporated Melt-stable amorphous lactide polymer film and process for manufacture thereof
BR9305658A (pt) * 1992-10-02 1996-11-26 Cargill Inc Papel tendo um polímero de lactideo estável em fusao e processo para sua produçao
US5338822A (en) * 1992-10-02 1994-08-16 Cargill, Incorporated Melt-stable lactide polymer composition and process for manufacture thereof
TW333456B (en) * 1992-12-07 1998-06-11 Takeda Pharm Ind Co Ltd A pharmaceutical composition of sustained-release preparation the invention relates to a pharmaceutical composition of sustained-release preparation which comprises a physiologically active peptide.
UA61046C2 (en) * 1992-12-07 2003-11-17 Takeda Chemical Industries Ltd Sustained-release preparation and method for its manufacture
WO1995003036A1 (en) 1993-07-19 1995-02-02 Angiogenesis Technologies, Inc. Anti-angiogenic compositions and methods of use
US5886026A (en) * 1993-07-19 1999-03-23 Angiotech Pharmaceuticals Inc. Anti-angiogenic compositions and methods of use
US5424289A (en) * 1993-07-30 1995-06-13 Alza Corporation Solid formulations of therapeutic proteins for gastrointestinal delivery
CA2143044C (en) * 1994-02-21 2005-04-12 Yasutaka Igari Matrix for sustained-release preparation
FR2718642B1 (fr) * 1994-04-15 1996-07-12 Pf Medicament Microsphères biodégradables à libération contrôlée et leur procédé de préparation.
US5626862A (en) 1994-08-02 1997-05-06 Massachusetts Institute Of Technology Controlled local delivery of chemotherapeutic agents for treating solid tumors
JP2987064B2 (ja) * 1994-09-12 1999-12-06 グンゼ株式会社 人工硬膜
US6117455A (en) * 1994-09-30 2000-09-12 Takeda Chemical Industries, Ltd. Sustained-release microcapsule of amorphous water-soluble pharmaceutical active agent
EP0753539B1 (en) * 1995-07-13 2001-10-10 Mitsubishi Gas Chemical Company, Inc. Aliphatic polyester polymer blends based on poly(lactic acid), methods for manufacturing the same, and methods for molding the same
EP0765660A3 (en) * 1995-09-28 1998-09-23 Takeda Chemical Industries, Ltd. Microcapsules comprising 2-piperazinone-1-acetic acid compounds
US5637085A (en) * 1995-11-20 1997-06-10 Cardinale; Robert M. Method of cancer tumor treatment by slow release delivery of 1,2,4-benzotriazine oxides to tumor site
DE19545257A1 (de) 1995-11-24 1997-06-19 Schering Ag Verfahren zur Herstellung von morphologisch einheitlichen Mikrokapseln sowie nach diesem Verfahren hergestellte Mikrokapseln
CA2192782C (en) 1995-12-15 2008-10-14 Nobuyuki Takechi Production of microspheres
FR2744367B1 (fr) * 1996-02-02 1999-07-09 Emperaire Jean Claude Medicaments pour le declenchement de l'ovulation
WO1997035563A2 (en) * 1996-03-28 1997-10-02 Takeda Chemical Industries, Ltd. Sustained-release preparation and its production
DE69734060T2 (de) 1996-05-24 2006-06-29 Angiotech Pharmaceuticals, Inc., Vancouver Zubereitungen und verfahren zur behandlung oder prävention von krankheiten der körperpassagewege
JP4317599B2 (ja) * 1996-06-26 2009-08-19 武田薬品工業株式会社 徐放性製剤
US7435425B2 (en) * 2001-07-17 2008-10-14 Baxter International, Inc. Dry hemostatic compositions and methods for their preparation
US7871637B2 (en) 1996-08-27 2011-01-18 Baxter International Inc. Dry hemostatic compositions and methods for their preparation
US8303981B2 (en) 1996-08-27 2012-11-06 Baxter International Inc. Fragmented polymeric compositions and methods for their use
US6066325A (en) * 1996-08-27 2000-05-23 Fusion Medical Technologies, Inc. Fragmented polymeric compositions and methods for their use
US8603511B2 (en) 1996-08-27 2013-12-10 Baxter International, Inc. Fragmented polymeric compositions and methods for their use
US7235524B2 (en) * 1997-01-31 2007-06-26 Applied Research System Ars Holding N.V. Medicaments for initiating ovulation
US5945126A (en) * 1997-02-13 1999-08-31 Oakwood Laboratories L.L.C. Continuous microsphere process
KR20010006026A (ko) 1997-04-03 2001-01-15 존스 홉킨스 유니버시티 스쿨 오브 메디슨 생물분해성 테레프탈레이트 폴리에스테르-폴리(포스페이트) 중합체, 조성물, 약품 및 그의 제조방법과 이용방법
US6051558A (en) * 1997-05-28 2000-04-18 Southern Biosystems, Inc. Compositions suitable for controlled release of the hormone GnRH and its analogs
ZA987019B (en) * 1997-08-06 1999-06-04 Focal Inc Hemostatic tissue sealants
KR19990065921A (ko) * 1998-01-19 1999-08-16 김충섭 항생제의서방성제제
US6099859A (en) * 1998-03-20 2000-08-08 Andrx Pharmaceuticals, Inc. Controlled release oral tablet having a unitary core
US6419709B1 (en) 1998-10-02 2002-07-16 Guilford Pharmaceuticals, Inc. Biodegradable terephthalate polyester-poly(Phosphite) compositions, articles, and methods of using the same
US6153212A (en) * 1998-10-02 2000-11-28 Guilford Pharmaceuticals Inc. Biodegradable terephthalate polyester-poly (phosphonate) compositions, articles, and methods of using the same
US6270802B1 (en) 1998-10-28 2001-08-07 Oakwood Laboratories L.L.C. Method and apparatus for formulating microspheres and microcapsules
GB2344287A (en) * 1998-12-03 2000-06-07 Ferring Bv Controlled release pharmaceutical formulation
EP1144507A3 (de) * 1998-12-15 2002-01-30 Wolff Walsrode Aktiengesellschaft Biologisch abbaubare, thermoplastische formkörper mit verbesserter hydrolysestabilität und spannungsrissbeständigkeit
US6350464B1 (en) * 1999-01-11 2002-02-26 Guilford Pharmaceuticals, Inc. Methods for treating ovarian cancer, poly (phosphoester) compositions, and biodegradable articles for same
US6537585B1 (en) 1999-03-26 2003-03-25 Guilford Pharmaceuticals, Inc. Methods and compositions for treating solid tumors
WO2002049620A2 (en) 2000-12-21 2002-06-27 Inhale Therapeutic Systems, Inc. Induced phase transition method for the production of microparticles containing hydrophobic active agents
CN1098883C (zh) * 2000-12-28 2003-01-15 武汉大学 分散度均匀的聚乳酸微球制备新方法
JP2004535431A (ja) 2001-06-22 2004-11-25 サザン バイオシステムズ， インコーポレイテッド ゼロ次長期放出同軸インプラント
US7314636B2 (en) 2001-06-29 2008-01-01 Medgraft Microtech, Inc. Biodegradable injectable implants containing glycolic acid
CN101444476B (zh) * 2001-12-26 2011-11-30 武田药品工业株式会社 新微球和其生产方法
JP2003192773A (ja) * 2001-12-26 2003-07-09 Mitsui Chemicals Inc 生体吸収性ポリヒドロキシカルボン酸及びその製造法
US20040197301A1 (en) * 2003-02-18 2004-10-07 Zhong Zhao Hybrid polymers and methods of making the same
US8834864B2 (en) * 2003-06-05 2014-09-16 Baxter International Inc. Methods for repairing and regenerating human dura mater
US7927626B2 (en) * 2003-08-07 2011-04-19 Ethicon, Inc. Process of making flowable hemostatic compositions and devices containing such compositions
US7645460B2 (en) * 2004-05-24 2010-01-12 The Procter & Gamble Company Dosage forms of risedronate
US7645459B2 (en) * 2004-05-24 2010-01-12 The Procter & Gamble Company Dosage forms of bisphosphonates
US20080287400A1 (en) * 2004-05-24 2008-11-20 Richard John Dansereau Low Dosage Forms Of Risedronate Or Its Salts
US20080286359A1 (en) * 2004-05-24 2008-11-20 Richard John Dansereau Low Dosage Forms Of Risedronate Or Its Salts
WO2006043644A1 (ja) * 2004-10-20 2006-04-27 National University Corporation Gunma University 温度応答性デプシペプチドポリマー
CN1923281B (zh) * 2005-08-30 2010-05-05 孔庆忠 一种含植物生物碱的抗癌缓释注射剂
WO2007084418A2 (en) * 2006-01-13 2007-07-26 Surmodics, Inc. Microparticle containing matrices for drug delivery
AU2007267338B2 (en) * 2006-05-31 2013-04-04 Baxter Healthcare S.A. Method for directed cell in-growth and controlled tissue regeneration in spinal surgery
TWI436793B (zh) * 2006-08-02 2014-05-11 Baxter Int 快速作用之乾密封膠及其使用和製造方法
KR100845009B1 (ko) * 2007-08-07 2008-07-08 한국생명공학연구원 전하를 띠는 물질이 고착된 다공성 고분자 입자 및 그제조방법
CN101842122B (zh) 2007-10-30 2013-12-25 巴克斯特国际公司 再生性生物功能胶原生物基质用于治疗内脏或腔壁缺损的应用
JP5569398B2 (ja) 2008-02-29 2014-08-13 フェッローサン メディカル ディバイス エー／エス 止血および／または創傷治癒を促進するための装置
US9039783B2 (en) * 2009-05-18 2015-05-26 Baxter International, Inc. Method for the improvement of mesh implant biocompatibility
EP2442835B1 (en) * 2009-06-16 2014-12-10 Baxter International Inc Hemostatic sponge
JPWO2011024944A1 (ja) * 2009-08-31 2013-01-31 国立大学法人豊橋技術科学大学 ステレオコンプレックスポリエステル及びその製造方法
KR101811070B1 (ko) * 2009-12-16 2017-12-20 백스터 인터내셔널 인코포레이티드 지혈 스폰지
SA111320355B1 (ar) 2010-04-07 2015-01-08 Baxter Heathcare S A إسفنجة لايقاف النزف
KR101814841B1 (ko) 2010-06-01 2018-01-03 백스터 인터내셔널 인코포레이티드 건조 및 안정한 지혈 조성물의 제조 방법
US8940335B2 (en) 2010-06-01 2015-01-27 Baxter International Inc. Process for making dry and stable hemostatic compositions
WO2011151400A1 (en) 2010-06-01 2011-12-08 Baxter International Inc. Process for making dry and stable hemostatic compositions
EP2598553B1 (en) * 2010-07-26 2016-04-27 Université de Genève Compositions comprising polymers prepared from 2-hydroxyalkyl acids
MX356185B (es) 2011-10-11 2018-05-17 Baxter Int Composiciones hemostaticas.
US20130090291A1 (en) 2011-10-11 2013-04-11 Baxter Healthcare S.A. Hemostatic compositions
RU2014121232A (ru) 2011-10-27 2015-12-10 Бакстер Интернэшнл Инк. Гемостатические композиции
CA2865349C (en) 2012-03-06 2021-07-06 Ferrosan Medical Devices A/S Pressurized container containing haemostatic paste
CA2874290C (en) 2012-06-12 2020-02-25 Ferrosan Medical Devices A/S Dry haemostatic composition
AU2014283170B2 (en) 2013-06-21 2017-11-02 Ferrosan Medical Devices A/S Vacuum expanded dry composition and syringe for retaining same
EP3470094B1 (en) 2013-12-11 2020-07-22 Ferrosan Medical Devices A/S Dry composition comprising an extrusion enhancer
BR112017007466B1 (pt) 2014-10-13 2021-03-02 Ferrosan Medical Devices A/S método para preparar uma composição seca, método para reconstituir a composição seca, pasta, composição seca, recipiente, kit homeostático, e, uso de uma composição seca
CN107206165B (zh) 2014-12-24 2020-10-23 弗罗桑医疗设备公司 用于保持并混合第一和第二物质的注射器
JP6747651B2 (ja) 2015-07-03 2020-08-26 フェロサン メディカル デバイシーズ エイ／エス 保管状態で真空を保持するための、及び２種の成分を混合するためのシリンジ
JP6148701B2 (ja) * 2015-07-31 2017-06-14 ユニベルシテ ドゥ ジュネーブ ２−ヒドロキシアルキル酸から調製されたポリマーを含む組成物
CN105111417A (zh) * 2015-08-25 2015-12-02 杭州铭众生物科技有限公司 一种羟基乙酸-羟基丙酸无规共聚物的制备方法
EP3790600B1 (en) 2018-05-09 2023-12-27 Ferrosan Medical Devices A/S Method for preparing a haemostatic composition

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US329526A (en) 1885-11-03 Coal-mining machine
US467719A (en) 1892-01-26 Dust-guard for car-axle journals
US368702A (en) 1887-08-23 bischoff
NO139560C (no) 1972-04-29 1979-04-04 Takeda Chemical Industries Ltd Analogifremgangsmaate til fremstilling av terapeutisk virksomme nonapeptidamid-derivater
JPS528375B2 (es) 1973-07-02 1977-03-09
FR2238700B1 (es) 1973-07-24 1977-10-14 Takeda Chemical Industries Ltd
AT347054B (de) 1973-09-29 1978-12-11 Takeda Chemical Industries Ltd Verfahren zur herstellung von neuen nonapeptidamid-derivaten
JPS5726506B2 (es) 1974-03-08 1982-06-04
FR2329293A1 (fr) 1975-10-29 1977-05-27 Parke Davis & Co Nouveaux nonapeptides et procedes pour leur production
US4087390A (en) 1977-02-02 1978-05-02 Eli Lilly And Company Somatostatin analogs and intermediates thereto
US4093574A (en) 1977-02-02 1978-06-06 Eli Lilly And Company Somatostatin analogs and intermediates thereto
JPS5944308B2 (ja) 1976-03-23 1984-10-29 武田薬品工業株式会社 ペプタイド
US4121577A (en) 1977-01-03 1978-10-24 Binder Timothy A Method and apparatus for aiding conditioning of an erect spinal column and advantageous muscle control
US4100117A (en) 1977-04-21 1978-07-11 Eli Lilly And Company Somatostatin analogs and intermediates thereto
US4253998A (en) 1979-03-09 1981-03-03 American Home Products Corporation Peptides related to somatostatin
US4277394A (en) 1979-04-23 1981-07-07 Takeda Chemical Industries, Ltd Tetrapeptidehydrazide derivatives
US4317815A (en) 1979-06-13 1982-03-02 Coy David Howard LH-RH Antagonists
US4622244A (en) * 1979-09-04 1986-11-11 The Washington University Process for preparation of microcapsules
US4253997A (en) 1979-12-17 1981-03-03 American Home Products Corporation Anti-ovulatory decapeptides
JPS5692846A (en) 1979-12-27 1981-07-27 Takeda Chem Ind Ltd Tetrapeptide derivative and its preparation
US4675189A (en) * 1980-11-18 1987-06-23 Syntex (U.S.A.) Inc. Microencapsulation of water soluble active polypeptides
PH19942A (en) * 1980-11-18 1986-08-14 Sintex Inc Microencapsulation of water soluble polypeptides
IE52535B1 (en) * 1981-02-16 1987-12-09 Ici Plc Continuous release pharmaceutical compositions
DE3218151A1 (de) * 1982-05-14 1983-11-17 Akzo Gmbh, 5600 Wuppertal Mikroporoese, pulverfoermige polylactide und verfahren zu deren herstellung
JPS60100516A (ja) * 1983-11-04 1985-06-04 Takeda Chem Ind Ltd 徐放型マイクロカプセルの製造法
CA1236641A (en) * 1984-07-06 1988-05-10 Motoaki Tanaka Copolymer of lactic acid and glycolic acid and method for producing same
JPH0678425B2 (ja) 1984-07-06 1994-10-05 和光純薬工業株式会社 重合体の新規製造法
ATE61935T1 (de) * 1985-02-07 1991-04-15 Takeda Chemical Industries Ltd Verfahren zur herstellung von mikrokapseln.
JP2551756B2 (ja) * 1985-05-07 1996-11-06 武田薬品工業株式会社 ポリオキシカルボン酸エステルおよびその製造法
US4962091A (en) * 1986-05-23 1990-10-09 Syntex (U.S.A.) Inc. Controlled release of macromolecular polypeptides
JP2526589B2 (ja) * 1986-08-08 1996-08-21 武田薬品工業株式会社 ペプチド含有マイクロカプセルおよびその製造法
JPH0725689B2 (ja) * 1986-10-07 1995-03-22 中外製薬株式会社 顆粒球コロニ−刺激因子を含有する徐放性製剤
AU606383B2 (en) * 1987-03-06 1991-02-07 Research Triangle Institute Polymer blends for selective biodegradability
JPH0613602B2 (ja) * 1987-07-14 1994-02-23 三井東圧化学株式会社 ｄ▲ｌ▼−乳酸−グリコール酸共重合物の製造方法
US4897811A (en) 1988-01-19 1990-01-30 Nestor, Inc. N-dimensional coulomb neural network which provides for cumulative learning of internal representations
JP2827287B2 (ja) * 1988-07-05 1998-11-25 武田薬品工業株式会社 水溶性薬物含有徐放型マイクロカプセル
DE68927904T2 (de) 1988-09-01 1997-09-04 Takeda Chemical Industries Ltd Fumagillol-Derivate
ES2053890T3 (es) 1988-09-01 1994-08-01 Takeda Chemical Industries Ltd Agente inhibidor de la angiogenesis.
JPH02212436A (ja) * 1989-02-14 1990-08-23 Japan Atom Energy Res Inst 徐放性基剤
EP0415294A3 (en) 1989-08-31 1991-06-12 Takeda Chemical Industries, Ltd. Cyclohexanol derivatives, production and use thereof
CN2891061Y (zh) 2006-03-15 2007-04-18 鸿富锦精密工业（深圳）有限公司 一体式液晶电脑及其电脑主机

Also Published As

Publication number Publication date
ZA918168B (en) 1993-04-14
US5304377A (en) 1994-04-19
UA27707C2 (uk) 2000-10-16
NO914032L (no) 1992-04-21
ES2069221T3 (es) 1995-05-01
CN1043189C (zh) 1999-05-05
IE913624A1 (en) 1992-04-22
KR100199119B1 (ko) 1999-06-15
CA2053468A1 (en) 1992-04-17
MX9101595A (es) 1992-06-05
EP0481732B1 (en) 1995-03-01
PT99236B (pt) 1999-04-30
FI101454B (fi) 1998-06-30
CN1057670C (zh) 2000-10-25
NO914032D0 (no) 1991-10-14
DE69107773T2 (de) 1995-06-29
DK0481732T3 (da) 1995-05-22
FI101454B1 (fi) 1998-06-30
FI914865A0 (fi) 1991-10-15
JPH05112468A (ja) 1993-05-07
IE66705B1 (en) 1996-01-24
RU2103005C1 (ru) 1998-01-27
AU8586491A (en) 1992-04-30
LTIP442A (en) 1994-11-25
NZ240214A (en) 1993-02-25
ATE119035T1 (de) 1995-03-15
EP0481732A1 (en) 1992-04-22
DE69107773D1 (de) 1995-04-06
FI914865A (fi) 1992-04-17
CN1060851A (zh) 1992-05-06
GEP19981287B (en) 1998-09-01
PT99236A (pt) 1992-09-30
AU644019B2 (en) 1993-12-02
CA2053468C (en) 2002-07-09
CN1116212A (zh) 1996-02-07
LV10055B (en) 1995-02-20
KR920007632A (ko) 1992-05-27
NO302481B1 (no) 1998-03-09
LT3277B (en) 1995-05-25
JP3196035B2 (ja) 2001-08-06
LV10055A (lv) 1994-05-10

Similar Documents

Publication Publication Date Title
EE02958B1 (et) Prolongeeritud toimega preparaat, polümeeride segu selle valmistamiseks ja polümeeride segu valmistamismeetod
ATE123649T1 (de) Feste pharmazeutische retardform.
GB1520197A (en) Stable antibiotic compositions
NZ224024A (en) Acrivastine sustained release compositions
NO983771L (no) Fremgangsmåte for fremstilling av tyggegummiblanding
TNSN90003A1 (fr) Derives de 2-aminopyrimidinones utiles notamment comme antagonistes des neurotransmetteurs et procede pour leur preparation
CA2076589A1 (en) Naphthylethylureas and naphthylethylthioureas, the process for their preparation and pharmaceutical compositions holding same
KR900013943A (ko) 장기작용성 제제용 약제-방출 조절 피복물질
NO914157D0 (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat
PT615754E (pt) Formas solidas de administracao oral de libertacao controlada flupertina
MY142066A (en) Controlled release composition comprising lactic acid polymer, and method of producing the same
AU3318389A (en) Azelastine-containing medicaments with controlled release of the active substance
KR0165901B1 (en) 4-[(2-BENZOTHIAZOLYL) METHYLAMINO]-Ñß-[(3,4-DIFLUOROPHENOXY)METHYL]-1-PIPERIDINE ETHANOL
FR2677546B1 (fr) Composition therapeutique pour liberation prolonge de magnesium.
OA09471A (fr) "Nouvelles benzothiazolinones substituées, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent".
UA84678C2 (ru) Фармацевтической композиции модифицированного высвобождения соли производного манделовой кислоты и ее применение для лечения сердечнососудистых нарушений
TH7154A (th) แอเซแลสทีนที่ประกอบอยู่ในสารที่ใช้รักษาโรคซึ่งควบคุมการปลดปล่อยสารแสดงฤทธิ์